EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor

Yidan Deng, Jianmei Wang, Di Wu, Lin Qin, Yuqi He, Daopeng Tan

Molecules · 2024

DOI: 10.3390/molecules29174080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yidan Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Engineering Research Center of Industrial Key-Technology for Dendrobium Nobile, Zunyi Medical University, Zunyi 563000, China. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Liposomes, Lipid Metabolism, Gynostemma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Engineering Research Center of Industrial Key-technology for Dendrobium Nobile, Zunyi of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is one of the most common metabolic diseases encountered in clinical practice, which is characterized by the excessive accumulation of triglycerides (steatosis), and a variety of metabolic abnormalities including lipid metabolism and bile acid metabolism are closely related to NAFLD. In China, Gynostemma pentaphyllum is used as functional food and Chinese medicine to treat various diseases, especially NAFLD, for a long time. However, the active components that exert the main therapeutic effects and their mechanisms remain unclear. In this study, Gypensapogenin A was isolated from the total saponins of G. pentaphyllum and prepared as a liposomal delivery system. Gypensapogenin A liposomes could activate FXR, inhibit the expression of CYP7A1 and CYP8B1, increase the expression of CYP27A1, modulate the ratio of CA and CDCA, decrease the content of CA, and increase the content of CDCA, thus forming a virtuous cycle of activating FXR to play a role in lowering blood lipid levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Cytoplasmic and NuclearLiposomesLipid MetabolismGynostemmaHumansAnimalsNon-alcoholic Fatty Liver DiseaseSaponinsHep G2 CellsMiceBile Acids and SaltsHepatocytesReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

FXRGynostemma pentaphyllumGypensapogenin Abile acidshyperlipidemia

Substanzen

Receptors, Cytoplasmic and NuclearLiposomesSaponinsBile Acids and SaltsReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • Guizhou Engineering Research Center of Industrial Key-Technology for Dendrobium Nobile, Zunyi Medical University, Zunyi 563000, China.
  • Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China.

Förderung

  • National Natural Science Foundation of China
  • Guizhou Engineering Research Center of Industrial Key-technology for Dendrobium Nobile
  • Zunyi of China
  • Department of Science and Technology of Guizhou Province
  • Zunyi Medical University Postgraduate Research Fund Project

Zitieren

APA

Deng, Y., Wang, J., Wu, D., Qin, L., He, Y., & Tan, D. (2024). Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor. Molecules. https://doi.org/10.3390/molecules29174080

Vancouver

Deng Y, Wang J, Wu D, Qin L, He Y, Tan D. Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor. Molecules. 2024. doi:10.3390/molecules29174080

BibTeX
@article{Deng2024,
  author = {Deng, Yidan and Wang, Jianmei and Wu, Di and Qin, Lin and He, Yuqi and Tan, Daopeng},
  title = {Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29174080}
}
Kostenlos starten →